imipramine has been researched along with Primary Myelofibrosis in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cortellazzo, S | 1 |
| Viero, P | 1 |
| Buczko, W | 1 |
| Barbui, T | 1 |
| de Gaetano, G | 1 |
1 other study available for imipramine and Primary Myelofibrosis
| Article | Year |
|---|---|
Platelet 5-hydroxytryptamine transport and storage in myeloproliferative disorders.
Topics: Adult; Aged; Biological Transport, Active; Blood Platelets; Female; Humans; Imipramine; Kinetics; Le | 1985 |